评估DiaFocus系统用于2型糖尿病综合个性化管理的临床可行性:为期6个月的试点队列研究
Nanna Lind1,2, Per Bækgaard3, Jakob E Bardram4
1Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Borgmester Ib Juuls vej 83, Herlev, 2730, Denmark, 45 28711435.
JMIR diabetes
|August 25, 2025
概括
这项试点研究发现DiaFocus移动卫生系统可用于2型糖尿病 (T2D) 管理. 虽然用户认为可以接受,但应用程序需要改进,并且没有观察到显著的临床结果变化.
科学领域:
- 数字卫生干预措施
- 慢性疾病管理
- 移动卫生系统
背景情况:
- 2型糖尿病 (T2D) 的管理需要患者和医疗保健专业人员之间持续的护理和共同的决策.
- 个人健康技术为监测,沟通和教育提供了工具,以支持协作糖尿病管理.
- 分享决策对于为个体需求量身定制T2D治疗计划至关重要.
研究的目的:
- 测试DiaFocus移动卫生系统对T2D成人的临床可行性和可接受性.
- 评估该系统在T2D护理中的可用性和影响.
- 评估用户参与DiaFocus系统中的特定自我管理重点领域.
主要方法:
- 一项为期6个月的单臂前性试点研究,涉及17名临床门诊的T2D成年人.
- 该系统包括一个参与者应用程序和一个HCP网络门户,收集生活方式数据,体育活动和用户选择的重点领域.
- 通过保留率,应用程序使用,参与者反和CACHET临床可行性评估统一方法 (CUMACF) 问卷进行了评估. 使用标准化问卷和生理数据测量临床结果.
主要成果:
- 在17名参与者中,有15人完成了这项研究;尽管存在技术问题,但该系统仍可用于T2D管理.
- 参与者高度重视设置焦点领域的能力,主要是"血糖"和"运动".
- 在CUMACF问卷中,用户对易用性 (90%) 和实用性 (80%) 的评价很高,积极的反表明他们愿意使用改进版本. 没有观察到临床结果的统计学意义上的变化.
结论:
- 对于T2D患者来说,DiaFocus系统在临床上是可行的和可接受的,它支持共享决策.
- 建议对应用程序的功能和稳定性进行优化,以提高用户体验和有效性.
- 虽然用户参与度是积极的,但需要进一步的研究来证明T2D管理的临床结果有显著的改善.
更多相关视频
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:15Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687